Article
Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. The TriVeneto Viral Hepatitis Group.
Hepatology (Baltimore, Md.) - 1 Sept 1995
Chemello L, Bonetti P, Cavalletto L, Talato F, Donadon V, Casarin P, Belussi F, Frezza M, Noventa F, Pontisso P
Abstract excerpt
Alpha-interferon (IFN-alpha) is an effective treatment for chronic hepatitis C, but only 20% to 30% of patients are apparently cured with the current recommended schedule of 3 MU given three times a week for 6 months. To evaluate the efficacy of more aggressive treatment regimens, we have conduct...
Topics
- Adult
- Aged
- Chronic Disease
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Genotype
- Hepacivirus
- Hepatitis C
- Humans
- Interferon alpha-2
- Interferon-alpha
- Male
- Middle Aged
- Multivariate Analysis